Baker Bros. Advisors (GP) LLC, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 371,689 shares at $71.61 ($26.7M) on 2019-01-22, disclosed to the SEC on 2019-01-22.
Open-market sale of $26.7M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.79 | 2,298 | $163K | 0.6% |
| 2 | $70.79 | 175 | $12K | 0.0% |
| 3 | $70.79 | 2,566 | $182K | 0.7% |
| 4 | $70.79 | 3,963 | $281K | 1.1% |
| 5 | $70.79 | 22,991 | $1.6M | 6.1% |
| 6 | $70.79 | 149,754 |
| $10.6M |
| 39.8% |
| 7 | $72.23 | 2,087 | $151K | 0.6% |
| 8 | $72.23 | 16 | $1K | 0.0% |
| 9 | $72.23 | 209 | $15K | 0.1% |
| 10 | $72.23 | 233 | $17K | 0.1% |
| 11 | $72.23 | 360 | $26K | 0.1% |
| 12 | $72.23 | 13,595 | $982K | 3.7% |
| 13 | $72.79 | 155 | $11K | 0.0% |
| 14 | $72.79 | 2,268 | $165K | 0.6% |
| 15 | $72.79 | 3,503 | $255K | 1.0% |
| 16 | $72.79 | 20,322 | $1.5M | 5.5% |
| 17 | $72.79 | 132,363 | $9.6M | 36.1% |
| 18 | $72.79 | 2,031 | $148K | 0.6% |
| 19 | $71.61 | 12 | $859 | 0.0% |
| 20 | $71.61 | 162 | $12K | 0.0% |
| 21 | $71.61 | 181 | $13K | 0.0% |
| 22 | $71.61 | 10,547 | $755K | 2.8% |
| 23 | $71.61 | 279 | $20K | 0.1% |
| 24 | $71.61 | 1,619 | $116K | 0.4% |
| Total | $71.75 avg | 371,689 | $26.7M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |